These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 1720164)

  • 1. [Effect of combinations of anticancer drugs with interferons on human lung cancer cell lines evaluated by human tumor clonogenic assay].
    Lee YC; Chang WJ; Yang PC
    J Formos Med Assoc; 1991 Sep; 90(9):880-5. PubMed ID: 1720164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colony inhibitory effect of recombinant human tumor necrosis factor (rH-TNF) and/or recombinant human interferon (rH-IFN)-alpha, -beta and -gamma on human lung cancer cell lines.
    Hong WS; Jett JR; Sasaki Y; Takahashi H; Nakano H; Nakagawa K; Hoshi A; Saijo N
    Jpn J Clin Oncol; 1987 Mar; 17(1):49-55. PubMed ID: 2435930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor effect of two-drug simultaneous or sequential use of cisplatin, vindesine or etoposide on human pulmonary adenocarcinoma cell lines in tumor clonogenic assay.
    Lee YC; Saijo N; Sasaki Y; Takahashi H; Sakurai M; Ishihara J; Sano T; Hoshi A; Chen KM; Hamburger AW
    Jpn J Cancer Res; 1986 Mar; 77(3):312-8. PubMed ID: 3084421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive interactions between human interferon and cepharanthin against human cancer cells in vitro and in vivo.
    Ono M; Tanaka N; Orita K
    Cancer Chemother Pharmacol; 1994; 35(1):10-6. PubMed ID: 7527303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of in vitro chemosensitivity and clinical responses to anticancer drugs in primary adenocarcinoma of the lung.
    Yang SC
    J Formos Med Assoc; 1990 Mar; 89(3):214-9. PubMed ID: 1974594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of clonogenic assays in assessing the response of human lung cancer cell lines to alpha and gamma interferons alone or in combination with adriamycin.
    Jabbar SA; Twentyman PR
    Int J Cancer; 1990 Sep; 46(3):546-51. PubMed ID: 2118486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination effects of TAS-103, a novel dual topoisomerase I and II inhibitor, with other anticancer agents on human small cell lung cancer cells.
    Sunami T; Nishio K; Kanzawa F; Fukuoka K; Kudoh S; Yoshikawa J; Saijo N
    Cancer Chemother Pharmacol; 1999; 43(5):394-401. PubMed ID: 10100595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiproliferative effects of interferons on human melanoma cells in the human tumor colony-forming assay.
    Schiller JH; Willson JK; Bittner G; Wolberg WH; Hawkins MJ; Borden EC
    J Interferon Res; 1986 Dec; 6(6):615-25. PubMed ID: 2437222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Probability of the combination use of cisplatin and carboplatin].
    Kobayashi K; Hino M; Hayashihara K; Niitani H
    Nihon Gan Chiryo Gakkai Shi; 1990 Nov; 25(11):2684-92. PubMed ID: 2277219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sensitivity testing of anticancer drugs using the human tumor clonogenic assay].
    Hiraki S; Ohnoshi T; Kishimoto N; Mori K; Nishii K; Yonei T; Yamashita H; Kimura I
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1208-13. PubMed ID: 3729443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-alpha and interferon-gamma combined with chemotherapy: in vitro sensitivity studies in non-small cell lung cancer cell lines.
    Hand A; Pelin K; Halme M; Ekman A; Mattson M; Vallas M; Mattson K; Linnainmaa K; Husgafvel-Pursiainen K
    Anticancer Drugs; 1993 Jun; 4(3):365-8. PubMed ID: 8395259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of selenium in combination with Adriamycin or Taxol on several different cancer cells.
    Vadgama JV; Wu Y; Shen D; Hsia S; Block J
    Anticancer Res; 2000; 20(3A):1391-414. PubMed ID: 10928049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro chemosensitivity tests of human lung small cell carcinomas--with reference to combination cancer chemotherapy].
    Inada T
    Nihon Geka Gakkai Zasshi; 1988 Feb; 89(2):256-64. PubMed ID: 2834634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines.
    Ohe Y; Nakagawa K; Fujiwara Y; Sasaki Y; Minato K; Bungo M; Niimi S; Horichi N; Fukuda M; Saijo N
    Cancer Res; 1989 Aug; 49(15):4098-102. PubMed ID: 2472873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro interactions of a new derivative of spicamycin, KRN5500, and other anticancer drugs using a three-dimensional model.
    Kanzawa F; Nishio K; Fukuoka K; Sunami T; Saijo N
    Cancer Chemother Pharmacol; 1999; 43(5):353-63. PubMed ID: 10100589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined antiproliferative activity of 5-fluorouracil and mitomycin-C against primary human ovarian tumors and cell lines in a clonogenic assay.
    Higashihara J; Berens ME; Collins LA; Homesley HD; Welander CE
    Gynecol Oncol; 1993 Feb; 48(2):171-9. PubMed ID: 8428687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Potentiation of the cytotoxic effects of anticancer drugs on human genitourinary neoplastic cells by recombinant gamma-interferon].
    Yamamoto S; Tanaka H; Namba M
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):699-705. PubMed ID: 3103539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Choice of second-line chemotherapy for advanced breast cancer based on the chemosensitivity assay by in vitro colony assay].
    Inoue K; Mukaiyama T; Yamazaki H; Horikoshi N; Ogawa M; Kobayashi T; Aiba K; Kuraishi Y
    Gan To Kagaku Ryoho; 1986 Feb; 13(2):356-61. PubMed ID: 3080968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antiproliferative effect of interferon-alpha on human renal cell carcinoma in clonogenic assay--single and combination effect with cancer chemotherapeutic agent].
    Ohmura K; Tsukamoto T
    Hinyokika Kiyo; 1989 May; 35(5):737-47. PubMed ID: 2801371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor effects of butyrolactone I, a selective cdc2 kinase inhibitor, on human lung cancer cell lines.
    Nishio K; Ishida T; Arioka H; Kurokawa H; Fukuoka K; Nomoto T; Fukumoto H; Yokote H; Saijo N
    Anticancer Res; 1996; 16(6B):3387-95. PubMed ID: 9042196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.